5-Bromo-3-iodo-1H-pyrazolo[5,4-b]pyridine: A Direct Manufacturer’s Perspective

Introducing a Distinctive Pyrazolopyridine Building Block

For years, we’ve focused on creating high-purity heterocyclic intermediates that offer synthetic chemists versatility and confidence. Among these, 5-bromo-3-iodo-1H-pyrazolo[5,4-b]pyridine (CAS 1055129-00-6) stands out. This molecule draws significant attention for its value in advanced pharmaceutical research, particularly in kinase inhibitor projects and emerging antiviral compounds. By refining our process and investing in repeatable batch controls, we bring customers a consistent product measured by a steady supply chain and reliable COA data.

Why Multihalogenated Scaffolds Matter

In the medchem sector, the dual halogenation pattern on this scaffold opens synthetic pathways that other structures can’t match. The bromine and iodine atoms sit at reactive positions, making the molecule primed for cross-coupling, such as Suzuki and Sonogashira reactions. Chemists can take advantage of the unique electronic influence each halide brings to the ring, guiding selectivity and yields when assembling more complex targets. It’s not every day you see a pyridopyrazole that combines both halogens in a single, cohesive backbone—this feature sets our molecule apart from more generic mono-halogenated or unsubstituted analogues.

Practical Manufacturing Experience Shapes Reliable Output

Scaling up this class of compound demands care, especially at the iodination step. We’ve learned that controlling water content and temperature through the route delivers clear advantages in crystal habit and shelf stability. Our process puts purity first, routinely above 98% by HPLC. We know from hard work on the line that trapping minor brominated byproducts early keeps downstream purifications efficient, saving both time and solvent. These lessons translate directly to fewer batch deviations and happy repeat customers.

Specifications and Batch Quality Assurance

Specifications tell part of the story; hands-on purification and analytical verification complete the picture. Our typical batches offer:

• Purity ≥98% by HPLC
• Moisture content well below 1%
• Identity confirmed by NMR (1H and 13C) and mass spectrometry
• No detectable mono-halogenated starting materials in the final isolated solid
• Light yellow, free-flowing crystalline powder

Each batch receives a full analytical workup before release. Since we control all upstream supply and every downstream unit operation, nobody outside our own team ever handles your intermediate during production. Our audits and storage protocols help preserve potency and avoid the contamination risks you sometimes hear about from less diligent outfits.

Applications and Research Impact

Medicinal chemists, process chemists, and discovery teams come to us for this molecule because of its uncommon reactivity. Through feedback over dozens of collaborations, we see most demand from teams advancing new kinase scaffolds, especially those layered with structure–activity relationship (SAR) studies involving core modifications. Some CROs request pilot-size lots for lead optimization; others integrate this building block into custom libraries for virtual screening. Since iodine enables easy Suzuki coupling and bromine offers yet another arylation handle, research chemists often run parallel reactions to assemble analogues fast—something not possible with structures capped by only one halogen.

The electron properties of this pyrazolopyridine ring system make it a clever starting point for researchers targeting CNS activity and anticancer screens. We’ve seen analogues using this core linked to a range of functional groups, from simple alkyls to intricate biaryl ethers. Feedback points again and again to how this bromo-iodo system helps groups both protect and then diversify their intermediates with predictable selectivity. Pharmas use it during scaffold hopping to move quickly between promising series; biotechs work with us to secure larger samples for IND-enabling synthesis. Our history with custom scale-up means we’re equipped to keep up with ever-changing project needs, offering technical support and flexible batch delivery on demand.

What Makes Ours Different

Not all 5-bromo-3-iodo-1H-pyrazolo[5,4-b]pyridine is created equal. We bring a background in heterocycle synthesis and a deliberate choice to avoid generic, off-the-shelf approaches. Some market samples show off-target halogenation—up to 5% in poorly monitored processes—that leads to surprises during late-stage coupling. We mitigate that at the source, holding every recrystallization to a clear standard. We use dedicated glassware for pyrazolo derivatives, sparing every batch the risk of leaching or cross-contamination with unrelated heterocycles or inorganic halides. Customers report cleaner NMRs, less baseline drag in HPLC, and improved reproducibility from our lots versus bulk offerings from trading houses.

Choice of Precursors Matters

From experience, the choice of pyrazolopyridine starting material shapes both output and impurity profile. A well-checked precursor, free from azide or nitro residues, ensures no decomposition crops up during halogenation. Our lab technicians document each run, cross-checking every analytic signal. We take nothing for granted—residual lithium salts, for instance, can trigger product instability during scale-up, so our crystallization stages include targeted wash protocols. There’s no shortcut for this detail-oriented approach, and by focusing on quality from step one, we avoid most rework and unexpected delays.

Meeting Evolving Regulatory and Purity Demands

As pharma regulations grow stricter on both intermediates and final APIs, full documentation and batch traceability become critical. We hold full batch records, controlled room logs, and can trace every bottle right back to precursor lots. Our goal never strays from supporting our partners’ audits and submissions, knowing a repeatable record lowers project risks and delays. Project managers and procurement teams echo this need—not only for COA reliability, but also for having real-time batch data on hand for data rooms and regulatory meetings. Our internal documentation meets or exceeds most multinational audit requirements.

Troubleshooting Common Manufacturing Issues

Problems during multi-halogenation show up occasionally even in the best-run labs. We’ve encountered challenges with incomplete bromination when temperature profiles stray or catalyst quality slips. To address this, our QC team pulls daily samples from production and checks completeness by both TLC and HPLC before moving to subsequent iodination steps. Failures in robust solvent drying, often overlooked in scale-up, sometimes trigger hydrolysis or lower yields; by integrating full solvent recycle and in-line drying, we reduce this risk in every batch. We believe fixing root causes in-house matters more than promising post-synthesis remedies. Our operators review every deviation, feeding insights back into future runs.

Improving Performance in Our Own Pipeline

Our process improvements aren’t theoretical—they come from direct trial and error. During crystal growth studies, we introduced controlled cooling and antisolvent addition to boost isolation yield by almost 15%. In one campaign, switching from a batch to a semi-continuous feed for the iodo reagent shortened overall reaction time without building up exotherms. This resulted in a cleaner intermediate before final workup, and a higher isolated yield with no extra purification passes required. Such tweaks grow from a deep knowledge of this particular chemistry, not the one-size-fits-all protocols found online.

Supporting Customers With Real Chemical Know-How

Scientists using our 5-bromo-3-iodo-1H-pyrazolo[5,4-b]pyridine call on us for more than material. We engage on project calls to troubleshoot coupling protocols, suggest compatible solvents, or propose deprotection sequences—not just to sell, but to help advance new target molecules. Some partners encountered batch-to-batch reactivity swings from other vendors; we helped them log exact coupling rates and compare across lots, revealing that lot purity and consistency, not just declared specs, drove their yields. A few times, switching to our material eliminated persistent side products that plagued earlier screens, letting customers claim precious weeks back in fast-paced SAR cycles.

Long-Term Relationships and Customization

Repeat buyers often request tailored quantities, packaging, or even milligram-scale pre-weighed vials for high-throughput campaigns. Our filling is done in a controlled enclosure, and every container gets double-barrier sealing to withstand long storage or overseas shipping. Because we run all these operations on-site, we can fulfill a 1 g sample or a 500 g lot using the same material from a single production lot, giving chemists full reproducibility from discovery through preclinical scale-up. In rare cases where a customer faces unique scale or time constraints, our process chemists work directly with them to reschedule or divide production phases, helping to smooth uncertain timelines.

Testing Real-World Applications

This compound doesn’t just occupy lab shelves—it finds its way into weekly project meetings and patent filings. One recurring pattern: research groups exploring kinase or immune-oncology pathways routinely report higher coupling yields and sharper spot profiles using this precise bromo-iodo core, compared with alternative mixed-halogen pyrazolopyridines. Teams running high-throughput screens praise the ease of handling, noting the powder stays free-flowing even after months under desiccator storage. Others use it as an early-stage scaffold to probe metabolic liabilities by building analogues that remain compatible with late-stage fluoride labeling or phase-transfer alkylations, an edge lost with less pure or more “sticky” analogues.

Why Real Manufacturing Matters

Chemical intermediates shape downstream innovation. Being deeply involved in every part of production, we see how a technician’s judgment—when to end an addition, how to spot subtle color shifts—feeds directly into the kind of reliability a chemist depends on. Subcontracted traders or faceless distributors don’t touch this level of care, and inevitably, we field calls from customers steered wrong by poor storage, outdated COAs, or puzzling impurity profiles. Our business remains grounded in getting every lot right, using both modern analysis and hard-earned shop-floor skills built over years of specialized heterocycle chemistry.

Looking Ahead: Meeting Future Project Needs

Demand for pyrazolo[5,4-b]pyridine building blocks, especially the bromo-iodo variant, only grows as more research teams chart new drug space. We respond by improving throughput and flexibility: shifting batch sizes as programs scale, and adding analytical capabilities to support trace-level impurity and elemental analyses. We continue to upgrade storage, packaging, and documentation for international partners under evolving regulatory pressure. Most importantly, we listen actively—every scientist’s feedback and every project’s result sharpens our chemical practice, leading to improvements across each new production run.

Differences From Other Products

What sets our 5-bromo-3-iodo-1H-pyrazolo[5,4-b]pyridine apart: it’s not a recycled or “re-labeled” product made in anonymous toll plants. Our in-house route uses the latest analytic tools matched to a physical QC team that checks every bottle. Other products on the market may offer only a single site for halogen substitution, narrowing reactivity, or come with a broader sideband of contaminants—particularly methylated or dehalogenated species that complicate late-stage synthesis. Our consistent method builds a uniform, predictable backbone, minimizing risk in downstream coupling or N-functionalization. Chemists moving into scale-up or filing for patent protection rely on this reliability to keep program momentum on track.

In practice, working directly with experienced chemical manufacturers saves time and headaches. If you’ve struggled with unreliable shipments, off-spec certificates, or unexplained reactivity loss, you see the impact a disciplined process has on both scientific and business outcomes. Trust in sourcing can make or break the crucial steps in preclinical campaigns or synthesis scale-ups.

A Collaborative and Transparent Approach

We stay transparent about each run’s details: yield fluctuations, analytical oddities, and packaging improvements are communicated openly. Chemists with tough questions reach technical staff directly—no call centers, no generic responses. This real dialogue, built on shared expertise and a genuine commitment to practical solutions, raises the bar for what a manufacturer can offer professional researchers. Trust grows run after run, not through advertising, but through direct, attentive service and reliable material.

Feedback Shapes Our Continual Improvements

Customer feedback doesn’t just fill out a survey—it shapes daily decisions in our plant. Researchers report how subtle improvements, such as narrowing batch-level impurity windows or offering interim certificates for samples in progress, feed directly into their speed and confidence. As academic and commercial needs shift, we adapt, offering new packaging, time-sensitive delivery, or bulk-lot reservations for long-term discovery programs. That adaptability, drawn from working closely with real-world chemists, keeps our products relevant, high performing, and respected across the industry.

Conclusion: Why Choose a Committed Manufacturer

Years of experience, a hands-on improvement mindset, and direct manufacturing oversight define how we deliver 5-bromo-3-iodo-1H-pyrazolo[5,4-b]pyridine. This commitment shows in both the chemistry and the service. We stand ready to support teams pushing boundaries, offering deep technical support, clear documentation, and steady supply at each stage of discovery and development. Every gram shipped reflects a combination of chemical know-how, tailored process controls, and a focus on making new science possible—never losing sight of the fact that behind every intermediate lies the potential for a breakthrough in medicine and beyond.